Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01720797 · ClinicalTrials.gov registry record · NA

Alveolar Microperforation for Inflammation-Enhanced Tooth Movement During Orthodontic Treatment

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT01720797 is a NA study that has completed, run by University of Florida. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01720797, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

The purpose of this research study is to assess the clinical effectiveness of the procedure of a minimally invasive alveolar microperforation procedure to achieve accelerated tooth movement in patients undergoing orthodontic treatment. "Accelerated tooth movement" means that using the PROPEL™ device may help complete your treatment with braces on one side of your mouth sooner than would be expected if the device were not to be used.

Interventions

  • OTHER Chlorhexidine
  • DEVICE Micro-osteoperforation
  • DRUG Anesthestic

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2013-02
Est. Completion 2015-04
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01720797

The ClinicalTrials.gov registry entry for NCT01720797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Chlorhexidine is the first listed.

NCT01720797 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01720797 about?

NCT01720797 is a clinical study titled "Alveolar Microperforation for Inflammation-Enhanced Tooth Movement During Orthodontic Treatment". The purpose of this research study is to assess the clinical effectiveness of the procedure of a minimally invasive alveolar microperforation procedure to achieve accelerated tooth movement in patients undergoing orthodontic treatment. "Accelerated tooth movement" means that using the PROPEL™ device...

What is the current status of trial NCT01720797?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-02. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01720797?

The interventions under investigation include: Chlorhexidine (OTHER), Micro-osteoperforation (DEVICE), Anesthestic (DRUG).

Who is sponsoring clinical trial NCT01720797?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.